What determine if a panel can be used for copy number analysis?
Just wondering what is (if any) the criteria for a targeted panel for copy number analysis? So targeted panel e.g. Agilent Glasgwow Cancer Core panel
Only some of the genes can be used for copy number variants. Is it the total size of the panel? or the size of the gene? or all the exons in the gene or certain % of the gene need to be targeted?
• 1,149 views
•
link
updated
by
German.M.Demidov
•
written
by
whb •
•
written
by
whb •
0 answers
No answers yet.
Log in to answer this question.
More posts like this
-
Freebayes VCF Post-Calling Filter Optimization: Schizophrenia Gene Panel Insights
written by Lukas •
-
A bash question
written by whb •
-
correct list of capture targets/intervals for SureSelect mouse exome to perform GATK Mutect2
written by ati_ •
-
bcl2fastq creates only Undetermined fastq
written by e.rempel
-
Help with Designing an Approach for Biomarker Signature Generation
written by JJ
-
Panel of tumors for CNV detection
written by biobiu
-
Exon number of chromosomal position
written by gero.knittel •
-
hg19 or hg38 for variant calling
written by jsneaththompson
-
DNAcopy for targeted sequencing
written by bdelolmo •
-
Is There A Practical Minimum Limitation Of Targeted Region Size To Enrich Using Sureselect Xt1
written by toshnam
I am a developer of CNV detection tools and I also don't understand what do they mean
It can be "it is not possible to detect short CNVs affecting this gene only", but normally somatic CNVs are quite long. The next page (page 3) shows that almost all the genes are suitable for CNA analysis - thus I assume it is not the case.
Maybe they performed some external validation and figured out this experimentally.